LongTec HongTao China Ventures

LongTec HongTao China Ventures functions as a specialized venture capital firm, dedicating its investment activities to the med tech and healthcare sectors. The firm strategically deploys capital into innovative medical technologies, actively supporting companies both in the United States and Israel. Its operational approach emphasizes fostering value creation between these global innovation hubs and the expansive Chinese market, cultivating advancements in critical medical fields.

The firm was founded by Peggy Wang, who serves as its Managing Director and Managing Partner. Her insight behind establishing LongTec HongTao China Ventures stemmed from recognizing the significant opportunity to bridge leading-edge medical technology developments from international markets with the unique demands and growth potential inherent in the Chinese healthcare landscape. This foundational vision aimed to facilitate the flow of innovation across borders.

LongTec HongTao China Ventures primarily serves companies developing advanced medical devices, diagnostics, and broader healthcare solutions. Its enduring vision is to cultivate a robust, globally interconnected ecosystem that accelerates the development and adoption of breakthrough medical technologies. The firm aims to consistently introduce sophisticated solutions to address pressing healthcare needs, ultimately shaping the future of medical care.